DANIELLE GEIGER: Open Payments
NPI 1598735763 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,572 in 9 payments from 9 companies in 2025. Trend: 2023 $738 · 2024 $336 · 2025 $2,572
Consulting: $1,524Speaker / faculty: $800Food & beverage: $248
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 1 | $880 |
| AVYXA PHARMA, LLC | 1 | $800 |
| E.R. Squibb & Sons, L.L.C. | 1 | $644 |
| ASD Specialty Healthcare, LLC | 1 | $125 |
| Genentech, Inc. | 1 | $35 |
| Gilead Sciences, Inc. | 1 | $33 |
| Amgen Inc. | 1 | $24 |
| EMD Serono, Inc. | 1 | $17 |
| PFIZER INC. | 1 | $15 |
Products named: ZYNYZ, Itovebi, Trodelvy, VECTIBIX, IBRANCE.
Industry payments across NE — which companies pay providers there.
